Antigenic distance measurements for seasonal influenza vaccine selection

Vaccine

Volumn 30, Issue 2, 2012, Pages 448-453

  Cai, Zhipeng ^a   Zhang, Tong ^b   Wan, Xiu Feng ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Antigenic cartography; Antigenic distance; Antigenic drift; Influenza; Vaccination; Vaccine strain selection

Indexed keywords

INFLUENZA VACCINE;

ANTIGEN DETECTION; ARTICLE; DRUG EFFICACY; HEMAGGLUTINATION INHIBITION; IMMUNOSURVEILLANCE; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; COMPUTER SIMULATION; CROSS REACTIONS; HUMANS; IMMUNOASSAY; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 84355162022     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.051     Document Type: Article

References (20)

1. Simonsen L., Fukuda K., Schonberger L.B., Cox N.J. The impact of influenza epidemics on hospitalizations. J Infect Dis 2010, 181(3):831-837.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N.J., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(2):179-186.
3. Lave J.R., Lin C.J., Fine M.J., Hughes-Cromick P. The cost of treating patients with community-acquired pneumonia. Sem Respir Crit Care Med 1999, 20:189-197.
4. CDC Estimates of deaths associated with seasonal Influenza - United States, 1976-2007. JAMA 2010, 304(16):1778-1780.
5. Frank A.L., Puck J., Hughes B.J., Cate T.R. Microneutralization test for influenza A and B and parainfluenza 1 and 2 viruses that uses continuous cell lines and fresh serum enhancement. J Clin Microbiol 1980, 12(3):426-432.
6. Perelson A., Oster G. Theoretical studies of clonal selection: minimal antibody repertoire size and reliability of self-non-self discrimination. J Theor Biol 1979, 81:645-667.
7. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Br Med Bull 1979, 35:69-75.
8. Arnold S.M., Maassab H.F. Ether treatment of type B influenza virus antigen for the Hemagglutination inhibition Test. J Clin Microbiol 1981, 13:54-57.
9. Smith D.J., Lapedes A.S., Forrest S., de Jong J., Osterhausa D.M.E., Fouchier A.M., et al. Modeling the effects of updating the influenza vaccine on the efficacy of repeated vaccination. Options for the control of influenza IV. Crete, Greece: Excerpta Medica, International Congress Series 1219 2001, 655-660. A.D. Osterhaus, N.J. Cox, A. Hampson (Eds.).
10. Smith D.J., Forrest S., Ackley D.H., Perelson A.S. Variable efficacy of repeated annual influenza vaccination. Proc Natl Acad Sci USA 1999, 94(24):14001-14006.
11. Fazekas de St Groth S., Webster R.G. Disquisitions on original antigenic sin. II. Proof in lower creatures. J Exp Med 1966, 124(3):347-361.
12. Webster R.G., Kasel J.A., Couch R.B., Laver W.G. Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans. J Exp Med 1976, 134(1):48-58.
13. Cai Z., Zhang T., Wan X.-F. A Computational framework for influenza antigenic cartography. PLoS Comput Biol 2010, 6(10):e1000949.
14. Cai, Z, Zhang, T and Wan X-F. Concepts and applications for influenza antigenic cartography. Influenza and Other Respiratory Viruses 2011; 5 (SUPPL. 1): 204-207.
15. Smith D., Lapedes A., Jong J., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 35:371-376.
16. Lapedes A., Farber R. The geometry of shape space: application to influenza. J Theor Biol 2001, 212(1):57-69.
17. Barr I., McCauley J., Cox N.J., Daniels R., Engelhardt O.G., Fukuda K., et al. Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009-2010 Northern Hemisphere season. Vaccine 2010, 28(5):1156-1167.
18. Bush R., Bender C., Subbarao K., Cox N.J., Fitch W. Emergence of a novel swine-origin influenza a (H1N1) virus in humans. Science 1999, 286:1921-1925.
19. WHO and OIE. Fao HN and Evolution Working Group. Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2008;14(7):e1.
20. WHO. Recommended composition of influenza virus vaccines for use in the 2009-2010 influenza season. WHO report; 2009.